CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $430,000 | -4.7% | 6,161 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $451,000 | +4.4% | 6,161 | -1.8% | 0.01% | +11.1% |
Q4 2013 | $432,000 | +5.6% | 6,277 | -2.5% | 0.01% | -10.0% |
Q3 2013 | $409,000 | +103.5% | 6,440 | +55.0% | 0.01% | +100.0% |
Q2 2013 | $201,000 | – | 4,154 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AKANTHOS CAPITAL MANAGEMENT LLC | 50,500 | $3,526,000 | 10.49% |
Palo Alto Investors LP | 1,526,916 | $106,609,000 | 7.94% |
HealthCor Management, L.P. | 1,225,000 | $85,530,000 | 4.29% |
SECTOR GAMMA AS | 192,490 | $13,440,000 | 3.18% |
AMI ASSET MANAGEMENT CORP | 363,698 | $25,393,000 | 2.52% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 578,207 | $40,370,000 | 2.01% |
TURNER INVESTMENTS LLC | 559,239 | $39,046,000 | 1.73% |
Tekla Capital Management LLC | 263,772 | $18,417,000 | 1.69% |
MAZAMA CAPITAL MANAGEMENT INC | 80,221 | $5,601,000 | 1.50% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,234,570 | $225,838,000 | 1.34% |